High-dose chemotherapy with hematopoietic stem-cell transplantation for breast cancer: current status, future trends.

Clinical breast cancer

Volumn 1, Issue 3, 2000, Pages

  Montemurro, F ^a   Ueno, N T ^a   Rondon G ^a   Aglietta, M ^a   Champlin, R E ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; FORECASTING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MORTALITY; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; FORECASTING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE;

MLCS; MLOWN;

EID: 0034309080     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/cbc.2000.n.016     Document Type: Review

References (118)